Drug usage evaluation (DUE) is a component of the Joint Commission on Accreditation of Healthcare Organizations guidelines for hospitals. If DUE is viewed with a positive focus rather than as simply a mandatory function, it can readily be exploited to benefit the institution. Study selection should be of practical use to the institution and study design should be as uncomplicated as possible. DUE may then be used to identify adverse drug reactions (ADRs), increase pharmacy staff, contain costs, and implement pharmaceutical care.
Get full access to this article
View all access options for this article.
References
1.
Accreditation Manual for Hospitals 1993: Joint Commission on Accreditation of Healthcare Organizations, Oakbrook Terrace, IL, 1992.
2.
BrodieDCSmithWE: Constructing a conceptual model of drug utilization review. Hospitals50:143–150, 1976.
3.
WibleDACaspiA (eds): Drug Usage Evaluation Blueprints. Hosp Ther13:25–35, 1988.
4.
StolarMH: Drug use review: Operational definitions. Am J Hosp Pharm35:76–78, 1978.
5.
Criteria for Drug Use Evaluation, Volumes 1 and 2: American Society of Hospital Pharmacists. Bethesda, MD, 1989, 1990.
6.
Network of two successfully revises hospital DUE program. Drug Util Rev9:26, 41, 1993.
7.
ThorntonJP: Drug usage evaluation: Focusing in on topic selection and indicator development. Hosp Pharm26:369, 394, 1991.
8.
MolineKA: Meeting JCAHO drug usage evaluation requirements in a small hospital. Hosp Pharm25:486–488, 1990.
9.
AdachiW: A simplistic approach to establishing drug usage/quality assurance programs. Hosp Pharm25:555–559, 1990.
10.
BricelandLLKaneMPHamiltonRA: Evaluation of patient-care interventions by Pharm.D. students. Am J Hosp Pharm49:1130–1132, 1992.
11.
ASHP statement on pharmaceutical care: Am J Hosp Pharm50:1720–1723, 1993.
12.
HeplerCDStrandLM: Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm47:533–543, 1990.
13.
Full-time DUR pharmacist improves patient care, saves hospital money. Drug Util Rev9:60–62, 1993.
14.
BerggrenPDAilorB: Drug use review and the medical staff reappointment process. Pharm Therapeut18:352–354, 1993.
15.
WullerWRMacKinnonGE: Incorporating DUE in the physician credentialing process. Pharm Therapeut18:457–462, 1993.
16.
NadzamDM: Development of medication-use indicators by the Joint Commission on Accreditation of Healthcare Organizations. Am J Hosp Pharm48:1925–1930, 1991.
17.
The wave of the future: Medication usage evaluation. Drug Util Rev8:129–131, 1992.
18.
Accreditation Manual for Hospitals 1994, Joint Commission on Accreditation of Healthcare Organizations, Oakbrook Terrace, IL, Pre-publication copy, April 1993.
19.
LewisRK: Disease audits and drug usage evaluation: Future performance evaluation tools for pharmaceutical care?Hosp Pharm26:265, 271, 1991.
20.
O'LearyDS: Agenda for change initiatives: Setting the record straight. Joint commission Perspectives, President's Column, March/April 1991.
21.
EnrightSMFlagstadMS: Quality and outcome: Pharmacy's professional imperative. Am J Hosp Pharm48:1908–1911, 1991.
22.
AngaranDM: Selecting, developing, and evaluating indicators. Am J Hosp Pharm48:1931–1937, 1991.
23.
BrushwoodDBCatizoneCACosterJM: OBRA 90: What it means to your practice. US Pharmacist64–72, October 1992.
